View in EDS

A controlled trial of taractan in chronic schizophrenia.

Saved in:
Bibliographic Details
Title: A controlled trial of taractan in chronic schizophrenia.
Authors: Scanlan, Eileen P., May, Arthur E., SCANLAN, E P (AUTHOR), MAY, A E (AUTHOR)
Source: British Journal of Psychiatry. May63, Vol. 109 Issue 460, p418-421. 4p. 3 Charts.
Subjects: Pharmaceutical research, Placebos, Drug efficacy, Behavioral medicine, Patients, Schizophrenia, Pathological laboratories, Clinical drug trials, Research, Heterocyclic compounds, Randomized controlled trials
Abstract: The article focuses on the study which aims to evaluate the drug Taractan in the treatment of chronic schizophrenia. Accordingly, Taractan is claimed to have neuroleptic and tranquillizing properties as well as thymoleptic activity. To test, 63 female chronic schizophrenics were divided into two groups; the first group were asked to take Taractan for the cure of the disease while the second group were tested with placebo. After two weeks without drugs, all patients were then assessed based on the psychotic reaction profile, clinical assessment rating scale, electroencephalogram, and pathological laboratory tests. After data interpretation, it was claimed that Taractan produces more improvement in chronic schizophrenics than a placebo.
Database: Psychology and Behavioral Sciences Collection
FullText Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 24758208
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A controlled trial of taractan in chronic schizophrenia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Scanlan%2C+Eileen+P%2E%22">Scanlan, Eileen P.</searchLink><br /><searchLink fieldCode="AR" term="%22May%2C+Arthur+E%2E%22">May, Arthur E.</searchLink><br /><searchLink fieldCode="AR" term="%22SCANLAN%2C+E+P%22">SCANLAN, E P</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22MAY%2C+A+E%22">MAY, A E</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22British+Journal+of+Psychiatry%22">British Journal of Psychiatry</searchLink>. May63, Vol. 109 Issue 460, p418-421. 4p. 3 Charts.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Pharmaceutical+research%22">Pharmaceutical research</searchLink><br /><searchLink fieldCode="DE" term="%22Placebos%22">Placebos</searchLink><br /><searchLink fieldCode="DE" term="%22Drug+efficacy%22">Drug efficacy</searchLink><br /><searchLink fieldCode="DE" term="%22Behavioral+medicine%22">Behavioral medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Patients%22">Patients</searchLink><br /><searchLink fieldCode="DE" term="%22Schizophrenia%22">Schizophrenia</searchLink><br /><searchLink fieldCode="DE" term="%22Pathological+laboratories%22">Pathological laboratories</searchLink><br /><searchLink fieldCode="DE" term="%22Clinical+drug+trials%22">Clinical drug trials</searchLink><br /><searchLink fieldCode="DE" term="%22Research%22">Research</searchLink><br /><searchLink fieldCode="DE" term="%22Heterocyclic+compounds%22">Heterocyclic compounds</searchLink><br /><searchLink fieldCode="DE" term="%22Randomized+controlled+trials%22">Randomized controlled trials</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: The article focuses on the study which aims to evaluate the drug Taractan in the treatment of chronic schizophrenia. Accordingly, Taractan is claimed to have neuroleptic and tranquillizing properties as well as thymoleptic activity. To test, 63 female chronic schizophrenics were divided into two groups; the first group were asked to take Taractan for the cure of the disease while the second group were tested with placebo. After two weeks without drugs, all patients were then assessed based on the psychotic reaction profile, clinical assessment rating scale, electroencephalogram, and pathological laboratory tests. After data interpretation, it was claimed that Taractan produces more improvement in chronic schizophrenics than a placebo.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=24758208
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1192/bjp.109.460.418
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 4
        StartPage: 418
    Subjects:
      – SubjectFull: Pharmaceutical research
        Type: general
      – SubjectFull: Placebos
        Type: general
      – SubjectFull: Drug efficacy
        Type: general
      – SubjectFull: Behavioral medicine
        Type: general
      – SubjectFull: Patients
        Type: general
      – SubjectFull: Schizophrenia
        Type: general
      – SubjectFull: Pathological laboratories
        Type: general
      – SubjectFull: Clinical drug trials
        Type: general
      – SubjectFull: Research
        Type: general
      – SubjectFull: Heterocyclic compounds
        Type: general
      – SubjectFull: Randomized controlled trials
        Type: general
    Titles:
      – TitleFull: A controlled trial of taractan in chronic schizophrenia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Scanlan, Eileen P.
      – PersonEntity:
          Name:
            NameFull: May, Arthur E.
      – PersonEntity:
          Name:
            NameFull: SCANLAN, E P
      – PersonEntity:
          Name:
            NameFull: MAY, A E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: May63
              Type: published
              Y: 1963
          Identifiers:
            – Type: issn-print
              Value: 00071250
          Numbering:
            – Type: volume
              Value: 109
            – Type: issue
              Value: 460
          Titles:
            – TitleFull: British Journal of Psychiatry
              Type: main
ResultId 1